help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 68, No. 4 801-807
doi:10.1210/jcem-68-4-801
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NAVOT, D.
Right arrow Articles by ROSENWAKS, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NAVOT, D.
Right arrow Articles by ROSENWAKS, Z.

Hormonal Manipulation of Endometrial Maturation

DANIEL NAVOT, TED L. ANDERSON, KATHLEEN DROESCH, RICHARD T. SCOTT, DAVID KREINER and ZEV ROSENWAKS*

Jones Institute for Reproductive Medicine and the Department of Obstetrics and Gynecology, Eastern Virginia Medical School Norfolk, Virginia 23507

Address requests for reprints to: Daniel Navot, M.D., Division of Reproductive Endocrinology, Box 1175, Department of Obstetrics and Gynecology, Mt. Sinai Medical Center, 1 Gustave L. Levy Place, New York, New York 10029.

Three experimental protocols were devised to induce endometrial maturation in 12 women with ovarian failure. Each was planned to serve a dual purpose: to resolve a particular clinical situation related to synchronization between ovum donor and recipient and to answer a specific question about endometrial physiology. A fourth protocol of sequential estrace (2–6 mg/day) and progesterone (P4; 25–50 mg/day, im) simulating the 28-day natural cycle, served as a control protocol (18 cycles). A short follicular phase protocol consisted of only 6 days of estrogen (E) administration before addition of P4 (13 cycles). In the long follicular phase protocol (5 cycles), estrace was given for 3–5 weeks, and P4 administration was accordingly postponed. In 6 accelerated secretory transformation cycles, 150 mg/day P4 were administered, im, from day 15 onward. The adequacy of the induced endometrial cycles was evaluated by hormonal, morphological, and histochemical criteria relevant to endometrial normalcy and receptivity. Serum estradiol levels and the areas under the estradiol curves for the long and short follicular phase protocols differed significantly from those during the control cycles (P < 0.005). Areas under the estradiol curves in the accelerated secretory transformation protocol yielded significantly higher P4 values than those in all other protocols (P < 0.05). All biopsies in the 3 experimental protocols compared favorably with those of the control protocol. Glycocalyx intensity (periodic acid-Schiff) and the amount of galactose residues in the glycocalyx (Ricinus communis-l agglutinin) were greatest during the periimplantation interval. We conclude that a very short exposure of the human endometrium to E or, conversely, prolonged E stimulation will allow normal endometrial maturation with the addition of P4. Supraphysiological doses of P4 in the accelerated secretory transformation protocol significantly enhanced endometrial maturational processes.

* Present address: Director of the Center for Reproductive Medicine and Infertility, The New York Hospital-Cornell Medical Center, 505 E. 70th St., P.O. Box 1, New York, New York 10021.

Received May 4, 1988.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
P.G. Groothuis, H.H.N.M. Dassen, A. Romano, and C. Punyadeera
Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human
Hum. Reprod. Update, July 1, 2007; 13(4): 405 - 417.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Pilka, I. Oborna, V. Lichnovsky, P. Havelka, H. Fingerova, P. Eriksson, S. Hansson, and B. Casslen
Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients
Hum. Reprod., December 1, 2006; 21(12): 3146 - 3156.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Brook, Y. Khalaf, A. Coomarasamy, J. Edgeworth, and P. Braude
A randomized controlled trial of prophylactic antibiotics (co-amoxiclav) prior to embryo transfer
Hum. Reprod., November 1, 2006; 21(11): 2911 - 2915.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. F. Vlahos, C. W. Lipari, B. Bankowski, T.-H. Lai, J. A. King, I.-M. Shih, K. Fragakis, and Y. Zhao
Effect of Luteal-Phase Support on Endometrial L-Selectin Ligand Expression after Recombinant Follicle-Stimulating Hormone and Ganirelix Acetate for in Vitro Fertilization
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4043 - 4049.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Babayof, E. J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva
Serum inhibin A, VEGF and TNF{alpha} levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial
Hum. Reprod., May 1, 2006; 21(5): 1260 - 1265.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kumar, Q. Li, A. Dua, Y.-K. Ying, M. K. Bagchi, and I. C. Bagchi
Messenger Ribonucleic Acid Encoding Interferon-Inducible Guanylate Binding Protein 1 Is Induced in Human Endometrium within the Putative Window of Implantation
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2420 - 2427.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Li, M. Zhang, S. Kumar, L.-J. Zhu, D. Chen, M. K. Bagchi, and I. C. Bagchi
Identification and Implantation Stage-Specific Expression of an Interferon-{{alpha}}-Regulated Gene in Human and Rat Endometrium
Endocrinology, June 1, 2001; 142(6): 2390 - 2400.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Tabibzadeh, J. M. Mason, W. Shea, Y. Cai, M. J. Murray, and B. Lessey
Dysregulated Expression of ebaf, a Novel Molecular Defect in the Endometria of Patients with Infertility
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2526 - 2536.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
C. Bebington, F.J. Doherty, G. Ndukwe, and S.D. Fleming
The progesterone receptor and ubiquitin are differentially regulated within the endometrial glands of the natural and stimulated cycle
Mol. Hum. Reprod., March 1, 2000; 6(3): 264 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kumar, L.-J. Zhu, M. Polihronis, S. T. Cameron, D. T. Baird, F. Schatz, A. Dua, Y.-K. Ying, M. K. Bagchi, and I. C. Bagchi
Progesterone Induces Calcitonin Gene Expression in Human Endometrium within the Putative Window of Implantation
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4443 - 4450.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society